A study on 28 AD patients and 25 HC found a negative correlation between serum Cu levels with CSF Aβ1–42, and a positive correlation with CSF t-tau levels [24], while oral intake of Cu showed no effect on CSF Aβ1–42, t-tau and p-tau levels in 68 AD patients [25]. Here, MAPT is linked to Alzheimer disease.